Gains access to global capital and market through the acquisition of controlling interest in Avra Medical Robotics, a NASDAQ-listed company in the USA

An Indian Medtech Start-up Company is ready to conquer the global market. India’s SS Innovation has now gained access to global capital & market through the acquisition of a controlling interest in Avra Medical Robotics, a Nasdaq-listed company in the United States. It is mentioned that the ingenious SSI Mantra, a brainchild of World-renowned robotic cardiac surgeon Dr Sudhir P Srivastava, has introduced a new era of surgical procedures in India, making robotic surgery accessible and affordable for the people of our country. Good Healthcare will no longer be a privilege for a few but will be accessible to all!

Dr Frederic Moll, Father of Robotic surgery, graced the announcement programme as the “Guest of Honour”. Dr Moll, is the founder of the World’s first surgical robot, the Da Vinci surgical system, and is World’s renowned medical device developer and entrepreneur, specialising in Robotic Surgery. He emphasised the importance of robotic surgery and the multiple benefits of this procedure over the traditional surgical methodology.

Dr Fredric Moll, Founder- Of Intuitive Surgical said, “Extremely excited to be here to witness the progress and development of a new robotic system that I believe is a great step forward for the general distribution of healthcare in the field of medical surgery. This system will provide the most advanced technology to patients around the globe, East and West alike. This technology is an opportunity to bring a major impact on contributing towards better healthcare and wellbeing of Asia and across her borders.”

SS Innovations has made the nation proud, being the first company in South Asia to launch the first fully “Made in India” surgical robot SSI Mantra, a technologically advanced surgical robotic system that has more and better features and applications than existing systems. This machine will revolutionize the idea of surgical practices in our homeland and around the world in terms of precision, technical advancement, and cost reduction, making expensive robotic surgery available for the common people.

On this momentous occasion, Dr Sudhir P Srivastava, Founder, Chairman & CEO, of SS Innovations said “This acquisition will help us reach the global market. Our innovation will be used widely. As we know that the future of Medtech lies in the precision of surgery and this acquisition will help us to bring this “Make in India” technology to the global platform. The union of Avra Medical Robotics with SSI will revolutionise the medical service all over the world hailing the spirit of Made in India, Atmanirbhar Bharat. We are very happy today to have some distinguished personalities with us like Dr Moll, the father of Robotics Surgery. The vision he had some 25 years back is now being manifested in full-fledged expression. We are all proud to be a part of this project. An Indian MedTech start-up will be there on NASDAQ, which is a proud moment for the entire nation.”

Bryan Knodel, a highly experienced and accomplished medical robotics scientist and Barry F Cohen, Founder, Chairman and CEO of Avra Medical Robotics Inc., USA were also present on the occasion of this important announcement.

On this merger, Barry F Cohen, Founder, Chairman and CEO of Avra Medical Robotics Inc., USA said, “It is wonderful to be here in India. I have visited this country many times over the last fifty years. Today stands as the No. one occasion for me so far. It is bringing together so much of my history, work and medicine. I am so happy for taking along my company Avra Medical Robotics into a marriage with Dr Srivastava’s SSI Innovations. We have combined the gifts of the East and the West to bring extremely accurate precision of Surgery to the people of the World. It is a good fortune; we wish to share it with the people. Good luck!

Avra Medical Robotics is pushing the transition from assistive to semi-autonomous treatments in healthcare with an initial focus on aesthetics. The company is constantly working on semi-autonomous systems. The Avra Robotic Treatment System (ARTS) allows providers to view a treatment plan and watch the treatment be performed purely by the robot using advanced guidance technology. With precision scanning, artificial intelligence, targeting, treatment, and information collection, their system provides boundless diagnostic and therapeutic implications for the healthcare space to target, diagnose, and treat.

With this merger, a new era of healthcare will soon be witnessed which will revolutionize the future of robotic surgeries across the Globe.